Is Anti-CD19 CAR T Cell therapy an efficacious and tolerable option for refractory SLE?
NSMC intern Susan Thanabalasingam explains it graphically
Is Anti-CD19 CAR T Cell therapy an efficacious and tolerable option for refractory SLE?
NSMC intern Susan Thanabalasingam explains it graphically
NSMC intern Mohamed Ibrahim created a beautiful visual abstract which simplifies the findings of CHIP study.
A detailed guideline like this deserves not one but two Visual Abstracts and the NSMC team has done justice to it. Here are two amazing VAs by Momen Abbasi and Priya John.
Look at this beautiful visual abstract from Cristina Popa